Beranda › Kanker Mulut › Minnesota › Duluth
Uji klinis Kanker Mulut di Duluth, MN
4 studi untuk Kanker Mulut mencari peserta di lokasi sekitar Duluth (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Hospital - Superior, Superior · 4 mi jauhnya
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Menerima pesertaFase 2
- Essentia Health Cancer Center, Duluth
- Essentia Health Saint Mary's Medical Center, Duluth
- Miller-Dwan Hospital, Duluth
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Menerima pesertaFase 2
- Miller-Dwan Hospital, Duluth
Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Essentia Health - Duluth Clinic, Duluth
- St. Luke's Hospital of Duluth, Duluth
Uji klinis Kanker Mulut di kota lain
- Atlanta, GA9 studi
- New York City, NY8 studi
- Chicago, IL8 studi
- St. Louis, MO8 studi
- Durham, NC7 studi
- Pittsburgh, PA7 studi
- Milwaukee, WI7 studi
- Ann Arbor, MI7 studi
- Kansas City, MO7 studi
- Houston, TX7 studi
- Richmond, VA7 studi
- Edison, NJ6 studi
Studi lain di Duluth
- Kanker Paru Non-Sel Kecil13 studi
- Kanker Paru11 studi
- Kanker Prostat7 studi
- Kanker Payudara7 studi
- Kanker Kolon6 studi
- Kanker Kandung Kemih6 studi
- Leukemia Mieloid Akut6 studi
- Kanker Endometrium5 studi
- Kanker Lambung5 studi
- Kanker Rektum5 studi
- Kanker Esofagus5 studi
- Kanker Laring5 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.